Home Dermatology PDF: Update on Drugs & Devices: November-December 2023
- You cannot add another "PDF: Non-Invasive Gene Expression Testing to Rule Out Melanoma" to your cart. View cart
Article
PDF: Update on Drugs & Devices: November-December 2023
$1.99
PDF Download: Update on Bimekizumab(Bimzelx®), Clindamycin 1.2%/ adapalene 0.15%/ benzoyl peroxide 3.1% fixed-dose topical gel (Cabtreo™), Roflumilast (Zoryve®), Nivolumab (Opdivo®), Secukinumab (Cosentyx®).
Read online:
Update on Drugs & Devices: November-December 2023
Related products
-
Article
PDF: Hydrogen Peroxide Topical Solution, 40% for the Treatment of Seborrheic Keratoses
$1.99 Add to cart -
Article
PDF: Update on Drugs & Devices: September – October 2019
$1.99 Add to cart -
Article
PDF: Real-World Efficacy of Azelaic Acid 15% Gel for the Reduction of Inflammatory Lesions of Rosacea
$1.99 Add to cart -
Article
PDF: Non-Invasive Gene Expression Testing to Rule Out Melanoma
$1.99 Add to cart
